Revised proposal from the Board's Nomination and Remuneration Committee to the Annual General Meeting of shareholders
(Thomson Reuters ONE) -
BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE April 7, 2010, at
3.00 p.m.
Revised proposal from the Board's Nomination and Remuneration Committee to the
Annual General Meeting of shareholders
Dr. Ann Hanham has informed that she no longer is available for re-election to
the Board of Directors of Biotie Therapies Corp. due to her recently emerged
other commitments. The Nomination and Remuneration Committee now proposes that
the number of members of the Board of Directors would be seven (7).
The Nomination and Remuneration Committee proposes that Peter Fellner, Bernd
Kastler, Pauli Marttila, Riku Rautsola and Pierre Serrure would be re-elected as
members of the Board of Directors and Merja Karhapää, Chief Legal Officer of
Sanoma Corporation, and James S. Shannon, CEO of Cerimon Phamaceuticals, Inc.,
would be elected as new members of the Board of Directors for the term expiring
at the end of the following annual general meeting. Ms. Karhapää and Dr.
Shannon have given their consent regarding the appointment.
In Turku, 7 April 2010
Biotie Therapies Corp.
Timo Veromaa, President and CEO
For further information, please contact:
Virve Nurmi, Biotie Therapies Corp.
tel.+358 2 274 8900, e-mail: virve.nurmi(at)biotie.com
www.biotie.com
Distribution:
NASDAQ OMX Helsinki Ltd
Main Media
[HUG#1401112]
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 07.04.2010 - 08:01 Uhr
Sprache: Deutsch
News-ID 1012524
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
Turku
Phone:
Kategorie:
Business News
Anmerkungen:
Diese Pressemitteilung wurde bisher 84 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Revised proposal from the Board's Nomination and Remuneration Committee to the Annual General Meeting of shareholders
"
steht unter der journalistisch-redaktionellen Verantwortung von
Biotie Therapies Oyj (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
